515 related articles for article (PubMed ID: 30782125)
1. Staphylococcus aureus with an erm-mediated constitutive macrolide-lincosamide-streptogramin B resistance phenotype has reduced susceptibility to the new ketolide, solithromycin.
Yao W; Xu G; Li D; Bai B; Wang H; Cheng H; Zheng J; Sun X; Lin Z; Deng Q; Yu Z
BMC Infect Dis; 2019 Feb; 19(1):175. PubMed ID: 30782125
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic and genotypic study of macrolide, lincosamide and streptogramin B (MLSB) resistance in clinical isolates of Staphylococcus aureus in Tehran, Iran.
Saderi H; Emadi B; Owlia P
Med Sci Monit; 2011 Feb; 17(2):BR48-53. PubMed ID: 21278685
[TBL] [Abstract][Full Text] [Related]
3. [The rare genes related to resistance to macrolide-lincosamide and streptogramin B group antibiotics among coagulase-negative staphylococci].
Sakar H; Mumcuoğlu I; Aksu N; Karahan ZC; Kurşun S; Kuştimur S
Mikrobiyol Bul; 2012 Apr; 46(2):170-9. PubMed ID: 22639306
[TBL] [Abstract][Full Text] [Related]
4. Solithromycin Can Specifically Induce Macrolide-Lincosamide-Streptogramin B Resistance.
Min YH
Microb Drug Resist; 2020 Sep; 26(9):1046-1049. PubMed ID: 32216609
[No Abstract] [Full Text] [Related]
5. Phenotypic and molecular characterization of resistance to macrolides, lincosamides and type B streptogramin of clinical isolates of Staphylococcus spp. of a university hospital in Recife, Pernambuco, Brazil.
Pereira JN; Rabelo MA; Lima JL; Neto AM; Lopes AC; Maciel MA
Braz J Infect Dis; 2016; 20(3):276-81. PubMed ID: 27094233
[TBL] [Abstract][Full Text] [Related]
6. [Macrolide-lincosamide-streptogramin B (MLSB) resistance phenotypes in clinical Staphylococcus isolates and investigation of telithromycin activity].
Uzun B; Güngör S; Pektaş B; Aksoy Gökmen A; Yula E; Koçal F; Kaya S
Mikrobiyol Bul; 2014 Jul; 48(3):469-76. PubMed ID: 25052113
[TBL] [Abstract][Full Text] [Related]
7. The antimicrobial activity of cethromycin against Staphylococcus aureus and compared with erythromycin and telithromycin.
Hu Y; Ouyang L; Li D; Deng X; Xu H; Yu Z; Fang Y; Zheng J; Chen Z; Zhang H
BMC Microbiol; 2023 Apr; 23(1):109. PubMed ID: 37081393
[TBL] [Abstract][Full Text] [Related]
8. [Investigation of macrolide, lincosamide and streptogramin B resistance in Staphylococcus aureus strains isolated from clinical samples by phenotypical and genotypical methods].
Aydeniz Ozansoy F; Cevahir N; Kaleli İ
Mikrobiyol Bul; 2015 Jan; 49(1):1-14. PubMed ID: 25706726
[TBL] [Abstract][Full Text] [Related]
9. [Investigation of macrolide-lincosamide-streptogramin B (MLS(B)) and telithromycin resistance in clinical strains of staphylococci].
Saribaş Z; Tunçkanat F; Ozçakir O; Ercis S
Mikrobiyol Bul; 2010 Apr; 44(2):177-86. PubMed ID: 20549951
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of macrolide, lincosamide, and streptogramin resistance among staphylococci in a tertiary care hospital in Athens, Greece.
Vallianou N; Evangelopoulos A; Hadjisoteriou M; Avlami A; Petrikkos G
J Chemother; 2015; 27(6):319-23. PubMed ID: 25112954
[TBL] [Abstract][Full Text] [Related]
11. Methicillin-susceptible Staphylococcus aureus ST398-t571 harbouring the macrolide-lincosamide-streptogramin B resistance gene erm(T) in Belgian hospitals.
Vandendriessche S; Kadlec K; Schwarz S; Denis O
J Antimicrob Chemother; 2011 Nov; 66(11):2455-9. PubMed ID: 21868413
[TBL] [Abstract][Full Text] [Related]
12. New Macrolide-Lincosamide-Streptogramin B Resistance Gene
Wipf JRK; Riley MC; Kania SA; Bemis DA; Andreis S; Schwendener S; Perreten V
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438941
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of solithromycin against erythromycin-resistant Streptococcus agalactiae.
Piccinelli G; Fernandes P; Bonfanti C; Caccuri F; Caruso A; De Francesco MA
Antimicrob Agents Chemother; 2014; 58(3):1693-8. PubMed ID: 24379197
[TBL] [Abstract][Full Text] [Related]
14. Macrolide-lincosamide-streptogramin B resistance phenotypes and their associated genotypes in Staphylococcus aureus isolates from a tertiary level public hospital of Uruguay.
Pardo L; Machado V; Cuello D; Aguerrebere P; Seija V; Braga V; Varela G
Rev Argent Microbiol; 2020; 52(3):202-210. PubMed ID: 31928835
[TBL] [Abstract][Full Text] [Related]
15. D test: a simple test with big implication for Staphylococcus aureus macrolide-lincosamide-streptograminB resistance pattern.
Shrestha B; Rana SS
Nepal Med Coll J; 2014 Sep; 16(1):88-94. PubMed ID: 25799821
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic and genotypic characterization of macrolide, lincosamide and streptogramin B resistance among clinical isolates of staphylococci in southwest of Iran.
Khashei R; Malekzadegan Y; Sedigh Ebrahim-Saraie H; Razavi Z
BMC Res Notes; 2018 Oct; 11(1):711. PubMed ID: 30305181
[TBL] [Abstract][Full Text] [Related]
17. Foggy D-shaped zone of inhibition in Staphylococcus aureus owing to a dual character of both inducible and constitutive resistance to macrolide-lincosamide-streptogramin B.
Yoon EJ; Kwon AR; Min YH; Choi EC
J Antimicrob Chemother; 2008 Mar; 61(3):533-40. PubMed ID: 18230691
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Inducible Macrolide, Lincosamide, and Streptogramin B (inducible MLSB) Resistance in Clindamycin-Susceptible Staphylococcus aureus at Okayama University Hospital.
Nahar L; Hagiya H; Nada T; Iio K; Gotoh K; Matsushita O; Otsuka F
Acta Med Okayama; 2023 Feb; 77(1):1-9. PubMed ID: 36849140
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of genotypes that determine resistance to macrolides, lincosamides, and streptogramins B compared with spiramycin susceptibility among erythromycin-resistant Staphylococcus epidermidis.
Juda M; Chudzik-Rzad B; Malm A
Mem Inst Oswaldo Cruz; 2016 Mar; 111(3):155-60. PubMed ID: 27008373
[TBL] [Abstract][Full Text] [Related]
20. Macrolide-lincosamide-streptogramin B resistance phenotypes in clinical staphylococcal isolates.
Cetin ES; Gunes H; Kaya S; Aridogan BC; Demirci M
Int J Antimicrob Agents; 2008 Apr; 31(4):364-8. PubMed ID: 18206352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
